2breathe Technologies unveiled 2breathe, a smart, connected device that aims to tackle sleeplessness via a guided breathing technology.
The device uses patented technology that grew out of a FDA-cleared device for non-drug treatment of hypertension and stress, RESPeRATE, which is already used by hundreds of thousands of doctors and patients. RESPeRATE’s one “side effect” was that users reported dozing off during the session and improved sleep. The company adapted the technology for smartphones and created the 2breathe platform to induce sleep.
2breathe relies on modern connected technology to deliver the ancient wisdom of sleep-inducing breathing exercises in an easy and effective manner. A sensor worn around the torso picks up the user’s inhale and exhale movements sending it to an iOS app via Bluetooth. The app converts breathing into tones that gradually guide the user to prolonged exhalation and slow breathing. Within minutes, neural sympathetic activity is reduced, the user begins to disassociate from both external and internal stimuli, and the mind and body relax into sleep. Once sleep is detected, 2breathe automatically shuts off and generates a report showing the falling asleep process breath-by-breath.
“We believe that tracking sleep is nice, but inducing sleep is better,” Erez Gavish, Co-Founder and CEO of 2breathe, said in a statement. “164 million Americans struggle with sleep at least once a week which is not surprising considering the extent of modern day work schedules and life stresses. We’re excited to be able to offer a real breakthrough to help those who cannot ‘shut off’ their minds and fall asleep.”
2breathe was recently introduced to the Japanese market by Teijin, Japan’s largest sleep provider and is now available to consumers for $179.95 directly at 2breathe.com.